caprolactone has been researched along with Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hira, SK; Manna, PP; Mishra, AK; Ray, B | 1 |
1 other study(ies) available for caprolactone and Lymphoma
Article | Year |
---|---|
Targeted delivery of doxorubicin-loaded poly (ε-caprolactone)-b-poly (N-vinylpyrrolidone) micelles enhances antitumor effect in lymphoma.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Caproates; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Humans; Lactones; Lymphoma; Mice; Micelles; Nanoparticles; Polymers; Pyrrolidinones; Tumor Burden; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2014 |